Home >Products> Medical Lab Instruments >Other Medical Lab Instruments> Price promotion ofCDX Model is coming
Medical Lab Instruments:  Microplate Readers / Plates Washers   Microbiological Analysis   Other Medical Lab Instruments  
Price promotion ofCDX Model is coming
Place of Origin:
China
Brand:
PharmaLegacy
Model:
HBMK430
Price:
1RMB
Hits:
354 
Updated:
8/26/2018
  • Product Detail
  • Company Profile

       

    PharmaLegacy Laboratories (Shanghai) Co., Ltdis a company with Honest and reliable CDX Model,CDX Modelx2a38631nandHumanized mouse model as the main business. We are committed to providing quality service of PDX Model. PharmaLegacy Laboratories (Shanghai) Co., Ltdwas established in 10 years ago, As a company with a high sense of social responsibility, PharmaLegacyhas established a high reputation for superior quality and expertise in Osteoporosis Modelfield

       PharmaLegacy Laboratories (Shanghai) Co., Ltdis committed to the continuous improvement of theCDX Modelservice, become a society, customers, shareholders and employees long-term trust of the company. Our Company adhering to pirit of for the sake of customers, and win-win with customers , and through PharmaLegacy staff continuous innovation and development to provide first-class CDX Model latest reference price,Efficient CDX Model,CDX Model conscience service,Provide professional CDX Model for enterprises , is what we have been working for. Details:Cell line-Derived Xenograft (CDX model) is a well-established and commonly used mouse tumor model type for the research and development of anti-tumor drugs and immunotherapy. More recently, human tumors implanted directly into immunodeficient mice have become increasingly popular as evidence accrues that they more accurately recapitulate features of patient tumors. However, CDX model still possesses pervasive application at the early stage of in vivo study, due to its user-friendly techniques as well as excellent repeatability.With decades of operational experience and technology platform of tumor cells, Pharmalegacy has established various well-validated cell-line-derived xenograft (CDX model) to satisfy your in vivo research, of which both solid tumors and precious hematological malignances models are available to customers. Our all-around products involve CDX model construction and delivery, in vivo projects execution as well as the final results presentation in the field of Oncology research.

       With the rapid development of business simultaneously, PharmaLegacy always keeps the balance between external opportunities and internal management, attaching great importance to the training and shaping of core competitiveness. The company will take customer service value as the core competitiveness of enterprises. Adhering to spirit of enterprise:acting with integrity , pursuit of excellence, respect for the individual , PharmaLegacystrives to provide customers with Provide professional DMPK. More details in the PharmaLegacyofficial website: www.pharmalegacy.com

    bio-equip.cn
    PharmaLegacy Laboratories is a leading speciality pharmacology Contract Research Organization located in Shanghai Zhangjiang High-Tech Park, China. PharmaLegacy is equipped with a world-class facility, working to international pharmaceutical industrial standards. PharmaLegacy provides preclinical in vivo pharmacology efficacy services as well a therapeutic antibody discovery service program. Our state-of-the-art platforms include:· Pioneering work using CD34+ humanized mice that carry a human immune system, to test biologics for immuno-oncology therapeutic efficacy· An NHP platform for therapeutic biologics testing in a variety of immune diseases · An advanced antibody discovery platform based on single B cell antibody sequencing · An internationally recognized Bone/Orthopaedics platform to test both hard tissue disease therapeutic candidates and medical devicesPharmaLegacy offers a full range of preclinical pharmacology services for evaluating pharmacological effects of drug candidates in the areas of inflammation/auto-Immune diseases, lung injury, liver/metabolic diseases and oncology. Our NHP platform and CD34+ humanized mice models have helped dozens of clients with IND filings
Request Information
Request Information: yes no
Request Quotation: yes no
refresh

I agree to share my inquiry with the other matching suppliers.

Request Information

* Name:
Job Title:
* Tel:
Fax:
* E-mail:
Postcode:
Institution/Company:
Address:
* Country:
Request Information:
yes no
Request Quotation:
yes no
* Message:
* Verification Code:
refresh
I agree to share my inquiry to the other matching suppliers.